Peizhi Zhao

Steven Zhao’s practice focuses on fund formation, private equity, wealth management, and general corporate matters. He has abundant experience advising on many influential projects in these areas.

In the field of fund establishment, Steven has represented renowned domestic and international private equity management institutions such as China Life, CICC Capital, CBRE, Blackstone, New Alliance Capital, China Renaissance, and SMIC Fund in setting up hundreds of investment funds. His investment-related experience spans biomedicine, real estate, insurance, high-end manufacturing, and artificial intelligence. Regarding private equity investment, Steven has participated in the private financing of enterprises in sectors such as TMT, medical, and high-end manufacturing, and on behalf of several funds under well-known institutions, including CICC Capital, China Renaissance, Softbank Asia, China Life Insurance, 3E Bioventures Capital, Meridian Capital China, and GL Capital Group. Additionally, he has provided legal consulting services to Intesa SanPaolo for its asset management business in China.

Steven has been recognized by various legal rating organizations, including: Chambers and Partners as a Leading Individual in the category of Investment funds and PE/VC in the Greater China Region Guide from 2025 to 2026; The Legal 500 Asia Pacific as a Key Lawyer - Investment Funds from 2023 to 2026, a Key Lawyer - PE/VC in 2022, and a Special Recommended Lawyer from 2021 to 2022; IFLR1000 as a Notable Practitioner in Private Equity from 2024 to 2025; China Business Law Journal as a Rising Star in 2022; LEGALBAND in the category of Top Ranked Lawyers - Investment Funds from 2020 to 2025, and China Lawyers of the Year 2021 (Special recommendation top 15 - Asset Management); DAWKINS as one of the Top Ranked Lawyers listed in the Fund Formation & Compliance category; and Interface News as one of the Interface Top 100 Lawyers in 2020.